Pharmaceuticals Market Research Reports & Industry Analysis

... from 7 viewpoints: 1. Renal Cell Carcinoma (RCC) - Disease Overview 2. Renal Cell Carcinoma (RCC) - Epidemiology 3. Global Renal Cell Carcinoma - Diagnosed Incident Cases to 2023 (8 Countries Covered) 4. Global Renal Cell Carcinoma - Five-Year Diagnosed ... (11 Brands Covered) 6. Global Renal Cell Carcinoma Drugs - Pipeline Analysis (18 Drugs Covered) 7. Global Renal Cell Carcinoma Drugs – Market Drivers and Restraints Global Renal Cell Carcinoma - Diagnosed Incident Cases ...

... pediatric vaccines market, while, bioCSl captures least share of the global pediatric vaccines market. Pediatric Vaccines Market - Disease Wise Company Sales Analysis GSK and Sanofi Pasteur generates maximum pediatric vaccines revenue ... Pediatric Vaccines Market - Disease Wise Analysis to 2021 2. Global Pediatric Vaccines Market - Company Sales Analysis and Strategic Alliances 3. Global Pediatric Vaccines - Disease Wise Company Sales and Forecast to 2021 4. Pediatric Vaccines Disease ...

Executive Summary Hearing aids and implants is witnessing growth on account of growing incidences of hearing loss globally where developed economies including ... 2016-2021) of the global hearing aids and implants market (global, regional, country-specific) by various segments (Hearing Aids and their sub-types: ...

... Global Malignant Melanoma Drug Market & Clinical Pipeline Insight” Report Highlight: Global Malignant Melanoma Market Analysis Malignant Melanoma Drug Mechanism of Action Global Malignant Melanoma Clinical Pipeline By Company & Phase Global Malignant Melanoma Clinical Pipeline: 201 Drugs Majority Malignant ...

... “Global Injectable Drug Market: Size, Trends and Forecasts (2016-2020)” provides an in-depth analysis of the global injectable market with detailed analysis of the actual and the expected market size along ... . The competition in the global injectable drug market is stiff and dominated by the big players like Pfizer, Inc. Further, key players of the injectable drug market such as Merck ...

... a part, so which model is best and what are the considerations which underpin that choice? This report analyses current orphan drug commercial models, assesses their ... for orphan drugs commercial teams to ensure that their business model works for all stakeholders? Key components: What are the key components of current commercial models ...

... is human vaccine apart from animal vaccine. Five pharmaceutical giants, MSD, Sanofi, Glaxo SmithKline, Pfizer and Novartis ... vaccines in the Vaccine II catalogue include Pneumonia Vaccine, Varicella Vaccine, Type B Haemophilus Influenzae Conjugate Vaccine, Influenza Vaccine and Rabies Vaccine. In China, Vaccine ...

... Japan Generics Drug Market Outlook 2020” Report Highlights: Introduction to Japanese Generic Drug Market Attractiveness of Japanese Generic Market Super Generics in Japan Japan Healthcare System & Generic Drugs Different Parameters for Generic & Branded Drugs Comparison of Generic Drugs in US & Japan Japan ...

... and emerging trends and dynamics in the world IV Ibuprofen market. The world IV Ibuprofen market is analyzed based on countries such as the U.S., Australia ... types of indications that will gain prominence in future. INTRAVENOUS (IV) IBUPROFEN MARKET KEY SEGMENTS: By Indication Pain/Inflammatory Fever By Age ...

... neem extract market. The neem extract market is bifurcated on the basis of application and geography. In 2015, Asia-Pacific was the highest revenue-generating region in the world neem extract market. Based on application ...

... prescription trends in the US generics market Performance of the US generics market compared to the pharmaceutical market Performance of the US generics market compared to other major markets Market structure of the US generics market Competitive landscape in the US generics market Top US generic ...

This report provides a worldwide strategic overview of the animal health market, including: Five-year forecasts for: Major market segments Key geographic regions Assessment of major U. S. and international trends with potentially significant impact on the animal health industry during the next five years, ...

Strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, ... profitability. This new report from VPG provides strategic assessment of Bayer's technological know-how, marketing tactics and strategic directions in the ...

Strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, ... profitability. This new report from VPG provides strategic assessment of Elanco's technological know-how, marketing tactics and strategic directions in the ...

Strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, ... profitability. This new report from VPG provides strategic assessment of Merial's technological know-how, marketing tactics and strategic directions in the ...

Strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, ... profitability. This new report from VPG provides strategic assessment of Phibro's technological know-how, marketing tactics and strategic directions in the ...

Strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, ... profitability. This new report from VPG provides strategic assessment of Virbac's technological know-how, marketing tactics and strategic directions in the ...

Strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, ... profitability. This new report from VPG provides strategic assessment of Zoetis' technological know-how, marketing tactics and strategic directions in the ...

... Lupin, Cipla, Sun pharma) and sustainable growth from Domestic formulation (e.g. Alkem, Cipla, Sun pharma, Dr Reddy), mainly from Chronic diseases’ segment, due to growth ... explore further opportunities of growth, Indian pharma companies have started developing complex generics/biosimilars. Almost all companies ...

... to develop drugs for specialty medicine (Multiple Sclerosis, Inflammatory Bowel Disease), Neurodegeneration (Alzheimer’s disease, Parkinson’s, ALS, Neuro-immunology) and rare diseases (Hemophilia, Spinal Muscular Atrophy and Neuropathic Pain). Celgene (CELG ...

2016 U.S. Drugs, health aids, beauty aids, including cosmetics sold through Other clothing stores-Product & Retail ... estimates on the sales of Drugs, health aids, beauty aids, including cosmetics sold through Other clothing stores nationally and for all 50 U.S. States and up to 900 metro ...

2016 U.S. Drugs, health aids, beauty aids, including cosmetics sold through Other home furnishings stores-Product & ... estimates on the sales of Drugs, health aids, beauty aids, including cosmetics sold through Other home furnishings stores nationally and for all 50 U.S. States and up to 900 ...

... , Edoxaban uptake in EU, Alectinib uptake in US and ACE-910 approval for hemophilia will decide Japanese Innovator growth in Global market. The biennial price cut scheduled in April-2016 ...

... Global T-Cell Lymphoma Market & Clinical Pipeline Insight” Report Highlight: Mechanism of T-Cell Lymphoma Therapeutics T-Cell Lymphoma Drug Market Overview T-Cell Lymphoma Drug Clinical Pipeline By Company & Phase T-Cell Lymphoma Drug Clinical Pipeline By Peripheral & Cutaneous T-cell Lymphoma T-Cell Lymphoma ...

... internal environment of the leading companies for strategy formulation. ANALGESICS MARKET KEY SEGMENTS: By Type Non-opioids Opioids By Route of Administration Oral Intravenous Rectal Transdermal Topical By Geography ...

... , what can Pharma do to ensure positive payer support for its pricing proposals? Pay-for-Performance and Drug Pricing Pressure: Impact and Response from Pharma intensively examines the ... setting the pay-for-performance vs pricing status quo agenda Understand how public payers are reforming health delivery and assess the likely impact on pharma ...

... development of vaccine is the major driver for the pediatric vaccine market. Increasing innovative technologies such as therapeutic and adjuvant vaccines are anticipated to fuel the pediatric vaccine market during the forecast period. Moreover, increasing expenditure of vaccines ...

... first in Belgium in 1986. Fluoxetine is a kind of selective serotonin reuptake inhibitors (SSRI) antidepressants and its medicinal form is Fluoxetine hydrochloride. Eli Lilly and ... number of Fluoxetine drugs on the market. There is a broad demand market of Fluoxetine in China. From 2010 to 2014, according to CRI’s survey on sample hospitals, CAGR of Fluoxetine is up to 9.68%. Eli ...

... more information: Market scale of Methylcobalamin in China Market Competitive pattern of Methylcobalamin in China Sales price of Methylcobalamin made by different enterprises in China Market outlook of Methylcobalamin in China The author recommends the following people to purchase this report: Production enterprises of methylcobalamin ...

... 4 viewpoints: 1. Influenza Vaccines Market, Persons Vaccinated and Forecast - Geographical Distribution (2011 - 2021) 2. Global - Influenza Vaccines Brand Sales and Forecast to 2021 3. Global Influenza Vaccines Market - Major Deals 4. Global Influenza Vaccines Market - Driving Factors and Challenges Influenza Vaccines Market, Persons Vaccinated and Forecast - Geographical Distribution ...

... and all those who are planning to foray into the Pharmaceutical Contract Packaging market in any manner. Key Questions Answered in This Report ... key success and risk factors in the Pharmaceutical Contract Packaging industry? How has the Pharmaceutical Contract Packaging market performed so far and how will it ...

... of opportunities available in the pharmaceutical packaging market on a global level. In order to give the users of this report a comprehensive view on the pharmaceutical packaging market, we have included ... the global pharmaceutical packaging market as follows: Global Pharmaceutical Packaging Market: Product Segment Analysis Plastic Bottles Parenteral Containers Blister Packaging, Other Primary Packaging Closures Labels Others Global Pharmaceutical Packaging Market ...

... prescription drugs Aruvian Research’s report – Canada Pharmaceutical Industry – explores the Canadian Pharmaceutical Industry landscape from the basics to ... going on in the Canadian pharmaceutical industry, Aruvian’s latest research is a collection of all you need to know about Canada’s Pharmaceutical Industry.

... Research’s report on Analyzing Edible Vaccines is an in depth study on the basics of vaccines and the major types of vaccines which are present in ... edible vaccines such as the role of transgenic plants. A complete section of Aruvian’s report on analyzing edible vaccines is devoted to the process of vaccine ...

... Generic Drugs Supportive Features of US Generic Drug Laws Effect of Generic Drug Import on US Economy Methods to Achieve Higher Cost Arbitrage by Generic Drugs Role of Online Pharmacies in Expansion of US Generic Drugs Market US Generic Drugs Market ...

Competitor Analysis: Dengue Virus Vaccines, Antibodies & Antivirals This Competitive Intelligence Report provides a competitor evaluation in the field of approved and investigational vaccines and therapeutics against one or more ... Dengue virus for prophylaxis of Dengue fever and of therapeutics for treatment of Dengue fever. In addition, the report lists company-specific R&D pipelines of Dengue Virus Vaccines, Antibodies and Antivirals. Competitor ...

Competitor Analysis: Flavivirus Vaccines: Zika, Dengue, Chikungunya, West Nile, Yellow Fever, Japanese Encephalitis & Tick-Borne Encephalitis Virus Vaccines The Competitive Intelligence Report Flavivirus Vaccines: Zika, Dengue, Chikungunya, West Nile, Yellow Fever, Japanese Encephalitis & Tick-Borne Encephalitis Virus Vaccines“ provides a competitor ...

... of the leading companies for strategy formulation. LAMEA ONCOLOGY/ANTI-CANCER DRUGS MARKET KEY SEGMENTS: LAMEA oncology/anti-cancer drugs market is segmented into therapeutic modalities, cancer types and countries. By Therapeutic modalities Chemotherapy ...

... factors driving as well as restraining the global bio-based platform chemicals market The market projections for the period 2014-2021 have been ... the business practices followed by the leading market players across various geographies BIO-BASED PLATFORM CHEMICALS MARKET KEY SEGMENTS: By Types C-3 Glycerol 3- ...

... developments withinthe world pharmaceutical excipients market is provided with key market dynamic factors that help in understanding the behavior of the market. The world pharmaceutical excipients market is segmented into ...

... more drugs in various phases of clinical trials, which will help in the growth of this market. According to the report “Global Renal Cell Carcinoma Drugs Market 2020”, the renal cell carcinoma drugs market is anticipated to cross US$ 4 Billion by 2020. The report provides a detailed analysis of the market for these drugs. The ...

... a profitable voice in the market? Effective Pharma KAM Teams: Challenges and Solutions from the front line shines a spotlight on the challenges facing KAM in 2016 and presents practical ... will get the best out of your KAM team Identify when and where KAM will be most effective and avoid wasting time and money ...

... friends when it comes to drug pricing. Public, health professional, political and payer hostility is growing worldwide as the prices of new drugs for chronic disease, specialty ... of justifying high drug prices to fund innovation and development need an overhaul? Risk Sharing: Are risk-sharing, value-based pricing and pricing by indication the best ...

... to Solid Tumors, attractive pricing option for orphan drug competitors and striking opportunities in developing orphan drugs. The report, “Global Orphan Drugs Market” analyzes the current prevailing condition of the ...

This report analyzes the worldwide markets for Prophylactic Human Vaccines in US$ Million by the following Product Segments: Pediatric Prophylactic Vaccines, and Adult Prophylactic Vaccines. The report provides separate ... 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

... of the company. The report segments the global cyclopentanone market as: Cyclopentanone Market: Application Segment Analysis Pharmaceuticals Biological Perfumes and aromas Rubber chemicals Insecticides Other (Including electronic solvents, paints and varnish removers, oil extraction) Cyclopentanone Market: Regional ...

... ). Human insulin drugs segment is expected to account for the larger share of the global human insulin market in 2015, followed by insulin delivery devices. Significant demand growth for human insulin drugs during ... : Market Penetration: Comprehensive information on the human insulin products offered by the top 10 players in the global market. The report analyzes the human insulin market by product, drug type, drug brand ...

The global market for drug repurposing will grow from nearly ... period of 2015-2020. The U.S. dominated the drug repurposing market and should reach approximately $13.7 in 2015 and close ... billion by 2020, rising at a CAGR of 5.4%. The non-U.S. market is expected to increase from $ 10.6 billion in 2015 to nearly ...

Without a doubt, the United States is the biggest market for pharmaceuticals in the world. It is also a world leader in biotechnology and ... . In this industry scenario, Aruvian Research presents a PEST analysis of the US pharmaceutical industry. A PEST analysis is concerned with the environmental influences on a ...

... expenses etc. have allowed the global telemedicine market to expand at an astonishing CAGR of 14.77% during 2015-2021. The expansion in the global telemedicine would open new great opportunities ... by 2021. As a result, the focus of technology providers can be seen shifting from Europe to Asia. GE, Philips, Honeywell etc. are some of the global telemedicine technology ...